Search Results

You are looking at 1 - 10 of 419 items for :

Clear All
Markus Eszlinger Departments of Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology, and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Heritage Medical Research Building, Calgary, Alberta, Canada
Institute of Pathology, University Hospital Halle (Saale), Halle (Saale), Germany

Search for other papers by Markus Eszlinger in
Google Scholar
PubMed
Close
,
Paul Stewardson Department of Medical Science and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada

Search for other papers by Paul Stewardson in
Google Scholar
PubMed
Close
,
John B McIntyre Precision Oncology Hub Laboratory, Alberta Health Services, Tom Baker Cancer Centre, Calgary, Alberta, Canada

Search for other papers by John B McIntyre in
Google Scholar
PubMed
Close
,
Adrian Box Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada

Search for other papers by Adrian Box in
Google Scholar
PubMed
Close
,
Moosa Khalil Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada

Search for other papers by Moosa Khalil in
Google Scholar
PubMed
Close
,
Martin Hyrcza Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada

Search for other papers by Martin Hyrcza in
Google Scholar
PubMed
Close
,
Konstantin Koro Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada

Search for other papers by Konstantin Koro in
Google Scholar
PubMed
Close
,
Dean Ruether Section of Medical Oncology, Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Canada

Search for other papers by Dean Ruether in
Google Scholar
PubMed
Close
,
Jiahui Wu Department of Medical Science and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada

Search for other papers by Jiahui Wu in
Google Scholar
PubMed
Close
, and
Ralf Paschke Departments of Medicine, Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology, and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Heritage Medical Research Building, Calgary, Alberta, Canada

Search for other papers by Ralf Paschke in
Google Scholar
PubMed
Close

mutation-positive medullary thyroid cancer (MTC) or RET gene fusion-positive thyroid cancer. The early approval of these drugs was based on phase 1/2 data ( 1 , 2 , 3 , 4 , 5 ). Patients with thyroid cancer were one of the larger patient groups in the

Open access
Thea Riis Department of Endocrinology, Odense University Hospital, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark

Search for other papers by Thea Riis in
Google Scholar
PubMed
Close
,
Steen Joop Bonnema Department of Endocrinology, Odense University Hospital, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark

Search for other papers by Steen Joop Bonnema in
Google Scholar
PubMed
Close
,
Thomas Heiberg Brix Department of Endocrinology, Odense University Hospital, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark

Search for other papers by Thomas Heiberg Brix in
Google Scholar
PubMed
Close
, and
Lars Folkestad Department of Endocrinology, Odense University Hospital, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark

Search for other papers by Lars Folkestad in
Google Scholar
PubMed
Close

Introduction Cancer is the second most common cause of death worldwide and imposes a burden both individually and to the health care systems ( 1 ). It has been suggested that four out of ten cancer cases are preventable ( 2 ). Therefore

Open access
Markus Eszlinger Department of Oncology and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Heritage Medical Research Building, Calgary, Alberta, Canada, and Institute of Pathology, University Hospital Halle, Halle, Germany

Search for other papers by Markus Eszlinger in
Google Scholar
PubMed
Close
,
Alexandra Stephenson Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Heritage Medical Research Building, Calgary, Alberta, Canada

Search for other papers by Alexandra Stephenson in
Google Scholar
PubMed
Close
,
Shideh Mirhadi Program in Cell Biology, Hospital for Sick Children, and Department of Molecular Genetics, University of Toronto, Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada

Search for other papers by Shideh Mirhadi in
Google Scholar
PubMed
Close
,
Konrad Patyra Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland

Search for other papers by Konrad Patyra in
Google Scholar
PubMed
Close
,
Michael F Moran Program in Cell Biology, Hospital for Sick Children, and Department of Molecular Genetics, University of Toronto, Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada

Search for other papers by Michael F Moran in
Google Scholar
PubMed
Close
,
Moosa Khalil Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Moosa Khalil in
Google Scholar
PubMed
Close
,
Jukka Kero Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland
Department of Pediatrics, Turku University Hospital, Turku, Finland

Search for other papers by Jukka Kero in
Google Scholar
PubMed
Close
, and
Ralf Paschke Department of Oncology and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Heritage Medical Research Building, Calgary, Alberta, Canada, and Institute of Pathology, University Hospital Halle, Halle, Germany
Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Heritage Medical Research Building, Calgary, Alberta, Canada
Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Department of Medicine, Cumming School of Medicine, University of Calgary, Heritage Medical Research Building, Calgary, Alberta, Canada

Search for other papers by Ralf Paschke in
Google Scholar
PubMed
Close

/hormone synthesis ( 4 , 5 , 6 , 7 , 8 , 9 ). At variance with most other thyroid nodules, current textbooks and guidelines assess HTN as a low cancer risk with no further malignancy evaluation recommended ( 10 ). To understand the role of TSHR signaling in

Open access
Lan Wu State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China

Search for other papers by Lan Wu in
Google Scholar
PubMed
Close
,
Salvatore Vaccarella International Agency for Research on Cancer (IARC/WHO), Lyon, France

Search for other papers by Salvatore Vaccarella in
Google Scholar
PubMed
Close
,
Chen-Yang Feng Information Technology Center, Sun Yat-sen University Cancer Center, Guangzhou, China

Search for other papers by Chen-Yang Feng in
Google Scholar
PubMed
Close
,
Luigino Dal Maso Unit of Cancer Epidemiology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy

Search for other papers by Luigino Dal Maso in
Google Scholar
PubMed
Close
,
Yu Chen State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China

Search for other papers by Yu Chen in
Google Scholar
PubMed
Close
,
Wei-Wei Liu Department of Head and Neck, Sun Yat-sen University Cancer Center, Guangzhou, China

Search for other papers by Wei-Wei Liu in
Google Scholar
PubMed
Close
,
Miao-Bian Liang State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China

Search for other papers by Miao-Bian Liang in
Google Scholar
PubMed
Close
,
Zike Zhang Department of Laboratory Medicine, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China

Search for other papers by Zike Zhang in
Google Scholar
PubMed
Close
,
Jun Yang School of Public Health, Guangzhou Medical University, Guangzhou, China

Search for other papers by Jun Yang in
Google Scholar
PubMed
Close
,
Su-Mei Cao State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China

Search for other papers by Su-Mei Cao in
Google Scholar
PubMed
Close
, and
Mengmeng Li State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China

Search for other papers by Mengmeng Li in
Google Scholar
PubMed
Close

Introduction Thyroid cancer is the most common cancer in the endocrine system, and its incidence rates have increased rapidly worldwide over the past decades, with relatively stable or declining mortality rates ( 1 , 2 ). The diverging gap

Open access
Stacey A. Fedewa Surveillance and Health Services Research, American Cancer Society, Atlanta, Ga., USA

Search for other papers by Stacey A. Fedewa in
Google Scholar
PubMed
Close
,
Ahmedin Jemal Surveillance and Health Services Research, American Cancer Society, Atlanta, Ga., USA

Search for other papers by Ahmedin Jemal in
Google Scholar
PubMed
Close
, and
Amy Y. Chen Department of Otolaryngology, Emory University School of Medicine, Atlanta, Ga., USA

Search for other papers by Amy Y. Chen in
Google Scholar
PubMed
Close

Introduction Each year, 64,300 men and women are diagnosed with thyroid cancer [ 1 ]. Approximately 90% of thyroid cancers are differentiated tumors comprised of papillary and follicular tumors that are commonly diagnosed at an early stage and

Free access
Brigitte Decallonne Department of Endocrinology, University Hospitals Leuven, Leuven, Belgium

Search for other papers by Brigitte Decallonne in
Google Scholar
PubMed
Close
,
Annick Van den Bruel Department of Endocrinology, General Hospital St Jan, Bruges, Belgium

Search for other papers by Annick Van den Bruel in
Google Scholar
PubMed
Close
,
Gilles Macq Department of Research, Belgian Cancer Registry, Brussels, Belgium

Search for other papers by Gilles Macq in
Google Scholar
PubMed
Close
,
Nathalie Elaut Department of Research, Belgian Cancer Registry, Brussels, Belgium

Search for other papers by Nathalie Elaut in
Google Scholar
PubMed
Close
, and
Harlinde De Schutter Department of Research, Belgian Cancer Registry, Brussels, Belgium

Search for other papers by Harlinde De Schutter in
Google Scholar
PubMed
Close

Introduction In Belgium, higher thyroid cancer incidence – most pronounced for microcancers (T1a) – is present in the Southern region, Wallonia, compared to the Northern region, Flanders. In a pioneer national population

Free access
Janice Ser Huey Tan Division of Radiation Oncology, National Cancer Centre Singapore, Hospital Boulevard, Singapore

Search for other papers by Janice Ser Huey Tan in
Google Scholar
PubMed
Close
,
Timothy Kwang Yong Tay Department of Pathology, Singapore General Hospital, Singapore

Search for other papers by Timothy Kwang Yong Tay in
Google Scholar
PubMed
Close
,
Enya Hui Wen Ong Division of Radiation Oncology, National Cancer Centre Singapore, Hospital Boulevard, Singapore

Search for other papers by Enya Hui Wen Ong in
Google Scholar
PubMed
Close
,
Michael Fehlings ImmunoScape, 1 Scotts Road #24-10, Singapore

Search for other papers by Michael Fehlings in
Google Scholar
PubMed
Close
,
Daniel Shao-Weng Tan Division of Medical Oncology, National Cancer Centre Singapore, Hospital Boulevard, Singapore

Search for other papers by Daniel Shao-Weng Tan in
Google Scholar
PubMed
Close
,
Nadiah Binte Sukma Department of Pathology, Singapore General Hospital, Singapore

Search for other papers by Nadiah Binte Sukma in
Google Scholar
PubMed
Close
,
Eileen Xueqin Chen Department of Pathology, Singapore General Hospital, Singapore

Search for other papers by Eileen Xueqin Chen in
Google Scholar
PubMed
Close
,
Jen-Hwei Sng Department of Pathology, Singapore General Hospital, Singapore

Search for other papers by Jen-Hwei Sng in
Google Scholar
PubMed
Close
,
Connie Siew Poh Yip Division of Radiation Oncology, National Cancer Centre Singapore, Hospital Boulevard, Singapore

Search for other papers by Connie Siew Poh Yip in
Google Scholar
PubMed
Close
,
Kok Hing Lim Department of Pathology, Singapore General Hospital, Singapore

Search for other papers by Kok Hing Lim in
Google Scholar
PubMed
Close
,
Darren Wan-Teck Lim Division of Medical Oncology, National Cancer Centre Singapore, Hospital Boulevard, Singapore

Search for other papers by Darren Wan-Teck Lim in
Google Scholar
PubMed
Close
,
Narayanan Gopalakrishna Iyer Division of Surgical Oncology, National Cancer Centre Singapore, Hospital Boulevard, Singapore

Search for other papers by Narayanan Gopalakrishna Iyer in
Google Scholar
PubMed
Close
,
Jacqueline Siok Gek Hwang Department of Pathology, Singapore General Hospital, Singapore

Search for other papers by Jacqueline Siok Gek Hwang in
Google Scholar
PubMed
Close
,
Melvin Lee Kiang Chua Division of Radiation Oncology, National Cancer Centre Singapore, Hospital Boulevard, Singapore

Search for other papers by Melvin Lee Kiang Chua in
Google Scholar
PubMed
Close
, and
Mei-Kim Ang Division of Medical Oncology, National Cancer Centre Singapore, Hospital Boulevard, Singapore

Search for other papers by Mei-Kim Ang in
Google Scholar
PubMed
Close

Introduction Anaplastic thyroid cancers (ATCs) are rare aggressive tumours, comprising only 1–2% of all thyroid cancers worldwide, and are typically associated with high mortality rates and a median overall survival (OS) of 5–12 months ( 1

Open access
Constance Xhaard U1018, Centre d'Epidémiologie et de Santé des Populations (CESP), Institut National de la Santé et de la Recherche Médicale (INSERM), Villejuif, France
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France

Search for other papers by Constance Xhaard in
Google Scholar
PubMed
Close
,
Juan J. Lence-Anta National Institute of Oncology and Radiobiology (INOR), Havana, Cuba

Search for other papers by Juan J. Lence-Anta in
Google Scholar
PubMed
Close
,
Yan Ren U1018, Centre d'Epidémiologie et de Santé des Populations (CESP), Institut National de la Santé et de la Recherche Médicale (INSERM), Villejuif, France
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France

Search for other papers by Yan Ren in
Google Scholar
PubMed
Close
,
Françoise Borson-Chazot Groupement Hospitalier Lyon-Est, Hospices Civils de Lyon, Fédération d'Endocrinologie, Bron
Rhône-Alpes Thyroid Cancer Registry, Cancer Research Center of Lyon (UMR INSERM 1052, CNRS 5286), RTH Laennec Faculty of Medicine, University of Lyon, Lyon

Search for other papers by Françoise Borson-Chazot in
Google Scholar
PubMed
Close
,
Geneviève Sassolas Rhône-Alpes Thyroid Cancer Registry, Cancer Research Center of Lyon (UMR INSERM 1052, CNRS 5286), RTH Laennec Faculty of Medicine, University of Lyon, Lyon

Search for other papers by Geneviève Sassolas in
Google Scholar
PubMed
Close
,
Claire Schvartz Thyroid Cancer Registry of Champagne-Ardennes, Institut Jean Godinot, Reims

Search for other papers by Claire Schvartz in
Google Scholar
PubMed
Close
,
Marc Colonna Cancer Registry of Isère, Meylan

Search for other papers by Marc Colonna in
Google Scholar
PubMed
Close
,
Brigitte Lacour Institut Gustave Roussy, Villejuif, France
French National Registry of Childhood Solid Tumours, CHU, Nancy

Search for other papers by Brigitte Lacour in
Google Scholar
PubMed
Close
,
Arlette Danzon Cancer Registry of Doubs, EA 3181, Université de Franche-Comté, Besançon

Search for other papers by Arlette Danzon in
Google Scholar
PubMed
Close
,
Michel Velten Cancer Registry of Bas-Rhin, EA 3430, Faculty of Medicine, University of Strasbourg, Strasbourg

Search for other papers by Michel Velten in
Google Scholar
PubMed
Close
,
Enora Clero U1018, Centre d'Epidémiologie et de Santé des Populations (CESP), Institut National de la Santé et de la Recherche Médicale (INSERM), Villejuif, France
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France

Search for other papers by Enora Clero in
Google Scholar
PubMed
Close
,
Stéphane Maillard U1018, Centre d'Epidémiologie et de Santé des Populations (CESP), Institut National de la Santé et de la Recherche Médicale (INSERM), Villejuif, France
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France

Search for other papers by Stéphane Maillard in
Google Scholar
PubMed
Close
,
Emilie Marrer Cancer Registry of Haut-Rhin, Mulhouse Hospital, Mulhouse

Search for other papers by Emilie Marrer in
Google Scholar
PubMed
Close
,
Laurent Bailly Public Health Department, University Hospital Nice, Nice

Search for other papers by Laurent Bailly in
Google Scholar
PubMed
Close
,
Eugènia Mariné Barjoan Public Health Department, University Hospital Nice, Nice

Search for other papers by Eugènia Mariné Barjoan in
Google Scholar
PubMed
Close
,
Martin Schlumberger Institut Gustave Roussy, Villejuif, France

Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
Close
,
Jacques Orgiazzi Department of Endocrinology, Hospices Civils de Lyon, Lyon, France

Search for other papers by Jacques Orgiazzi in
Google Scholar
PubMed
Close
,
Elisabeth Adjadj U1018, Centre d'Epidémiologie et de Santé des Populations (CESP), Institut National de la Santé et de la Recherche Médicale (INSERM), Villejuif, France
Université Paris-Saclay, Villejuif, France

Search for other papers by Elisabeth Adjadj in
Google Scholar
PubMed
Close
,
Celia M. Pereda National Institute of Oncology and Radiobiology (INOR), Havana, Cuba

Search for other papers by Celia M. Pereda in
Google Scholar
PubMed
Close
,
Silvia Turcios National Institute of Endocrinology, Cuba

Search for other papers by Silvia Turcios in
Google Scholar
PubMed
Close
,
Milagros Velasco National Institute of Oncology and Radiobiology (INOR), Havana, Cuba

Search for other papers by Milagros Velasco in
Google Scholar
PubMed
Close
,
Mae Chappe National Institute of Oncology and Radiobiology (INOR), Havana, Cuba

Search for other papers by Mae Chappe in
Google Scholar
PubMed
Close
,
Idalmis Infante National Institute of Oncology and Radiobiology (INOR), Havana, Cuba

Search for other papers by Idalmis Infante in
Google Scholar
PubMed
Close
,
Marlene Bustillo National Institute of Oncology and Radiobiology (INOR), Havana, Cuba

Search for other papers by Marlene Bustillo in
Google Scholar
PubMed
Close
,
Anabel García National Institute of Oncology and Radiobiology (INOR), Havana, Cuba

Search for other papers by Anabel García in
Google Scholar
PubMed
Close
,
Sirced Salazar National Institute of Oncology and Radiobiology (INOR), Havana, Cuba

Search for other papers by Sirced Salazar in
Google Scholar
PubMed
Close
,
Regla Rodriguez Cuban Public Health Ministry, Havana, Cuba

Search for other papers by Regla Rodriguez in
Google Scholar
PubMed
Close
,
Mohamed Amine Benadjaoud U1018, Centre d'Epidémiologie et de Santé des Populations (CESP), Institut National de la Santé et de la Recherche Médicale (INSERM), Villejuif, France
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France

Search for other papers by Mohamed Amine Benadjaoud in
Google Scholar
PubMed
Close
,
Rosa M. Ortiz National Institute of Oncology and Radiobiology (INOR), Havana, Cuba

Search for other papers by Rosa M. Ortiz in
Google Scholar
PubMed
Close
,
Carole Rubino U1018, Centre d'Epidémiologie et de Santé des Populations (CESP), Institut National de la Santé et de la Recherche Médicale (INSERM), Villejuif, France
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France

Search for other papers by Carole Rubino in
Google Scholar
PubMed
Close
, and
Florent de Vathaire U1018, Centre d'Epidémiologie et de Santé des Populations (CESP), Institut National de la Santé et de la Recherche Médicale (INSERM), Villejuif, France
Institut Gustave Roussy, Villejuif, France
Université Paris-Saclay, Villejuif, France

Search for other papers by Florent de Vathaire in
Google Scholar
PubMed
Close

Introduction Over the last few decades, the differentiated thyroid cancer (DTC) incidence has grown rapidly in many countries [ 1 ]. The study of DTC risk factors is therefore of great importance to understand this observed increase in

Free access
Aamna Hassan Departments of Nuclear Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan

Search for other papers by Aamna Hassan in
Google Scholar
PubMed
Close
,
Saima Riaz Departments of Nuclear Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan

Search for other papers by Saima Riaz in
Google Scholar
PubMed
Close
,
Humayun Bashir Departments of Nuclear Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan

Search for other papers by Humayun Bashir in
Google Scholar
PubMed
Close
,
M. Khalid Nawaz Departments of Nuclear Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan

Search for other papers by M. Khalid Nawaz in
Google Scholar
PubMed
Close
, and
Raza Hussain Departments of Surgical Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan

Search for other papers by Raza Hussain in
Google Scholar
PubMed
Close

Introduction Differentiated thyroid cancer (DTC) is typically indolent if treated early and appropriately. A small subset of more aggressive disease progresses to radioiodine resistance. Based on the American Thyroid Association (ATA) risk of

Free access
Patrick W. Owens Discipline of Surgery, Lambe Institute for Translational Research, NUI Galway, Galway, Ireland

Search for other papers by Patrick W. Owens in
Google Scholar
PubMed
Close
,
Terri P. McVeigh Discipline of Surgery, Lambe Institute for Translational Research, NUI Galway, Galway, Ireland
Cancer Genetics Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom

Search for other papers by Terri P. McVeigh in
Google Scholar
PubMed
Close
,
Eoin J. Fahey Discipline of Surgery, Lambe Institute for Translational Research, NUI Galway, Galway, Ireland

Search for other papers by Eoin J. Fahey in
Google Scholar
PubMed
Close
,
Marcia Bell Department of Endocrinology, Galway University Hospital, Galway, Ireland

Search for other papers by Marcia Bell in
Google Scholar
PubMed
Close
,
Denis S. Quill Discipline of Surgery, Lambe Institute for Translational Research, NUI Galway, Galway, Ireland

Search for other papers by Denis S. Quill in
Google Scholar
PubMed
Close
,
Michael J. Kerin Discipline of Surgery, Lambe Institute for Translational Research, NUI Galway, Galway, Ireland

Search for other papers by Michael J. Kerin in
Google Scholar
PubMed
Close
, and
Aoife J. Lowery Discipline of Surgery, Lambe Institute for Translational Research, NUI Galway, Galway, Ireland

Search for other papers by Aoife J. Lowery in
Google Scholar
PubMed
Close

Introduction Thyroid cancer (TC) is the most common endocrine malignancy, accounting for 1% of all cancers, with an incidence of 162 cases per year in Ireland [ 1 ]. The National Cancer Registry Ireland reports increasing incidence of TC from

Free access